Mir Ali, MD, medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, calls NAION a rare and unusual side effect of semaglutide, noting that the vast majority of people who use this medication dont experience the eye condition
AACE explicitly acknowledges that formulary constraints often drive brand selection when the same molecule is available under multiple trade names
Worth it at low doses where every microgram matters
As GLP-1 analogs, GLP-1RAs effectively regulate blood glucose by inhibiting glucagon secretion, slowing gastric emptying, enhancing insulin sensitivity, and stimulating insulin secretion [51]
08.01.25 August monthly MDL report: More than 2,000 active cases The number of active claims in the MDL grew past 2,000, marking 2,190 active GLP-1 lawsuits, including Wegovy claims